Eurosurveillance banner


The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Monthly Release  2002: Volume 7/ Issue 2 Article 4 Printer friendly version
Back to Table of Contents
en es fr it
Previous

Eurosurveillance, Volume 7, Issue 2, 01 February 2002
Scientific review
Monitoring HIV prevalence and behaviour of men who have sex with men in Barcelona, Spain

Citation style for this article: Pérez K, Rodes A, Casabona Barbarà J. Monitoring HIV prevalence and behaviour of men who have sex with men in Barcelona, Spain. Euro Surveill. 2002;7(2):pii=345. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=345
K. Pérez, A. Rodes, J. Casabona

Centre for Epidemiological Studies on AIDS of Catalonia (CEESCAT), Badalona, Spain.

Recently, different studies among men who have sex with men (MSMs) have reported an increase in HIV incidence and sexually transmitted infections, and an increase in sexual risk behaviour. But the optimism regarding anti-retroviral treatments may lead to a greater relaxation in protective measures in the near future.
 

Introduction

Catalonia is an autonomous region in Spain with six million inhabitants. By December 2000, 13 275 cases of AIDS had been reported and the annual AIDS incidence rate was 81.8 per million in 2000. As a transmission group, homosexual men represented 20% of the total number of AIDS cases in 2000, showing a slight increase since 1998 (17.6%) (1). As part of the Sistema integrat de vigilància epidemiològica de l’HIV/sida a Catalunya (Catalan integrated surveillance system of HIV/AIDS), monitoring of HIV and sexual risk behaviour among men who have sex with men (MSMs) was introduced in 1993 (2).

Recently, different studies among MSMs have reported an increase in HIV incidence (3-5) and sexually transmitted infections (6-8), and an increase in sexual risk behaviour (9,10). This change to unsafe sexual behaviour has been explained in part by the optimism surrounding HIV treatment and the absence of the threat of death that existed a decade ago. Some authors found a significant relationship between unprotected anal intercourse and certain aspects of optimism in the context of new HIV treatments (11-12).

The objectives of this paper are to describe the trends in prevalence of HIV infection and in risk behaviour in 1995, 1998, and 2000 among MSMs recruited in different venues in Barcelona; to describe trends in knowledge and perception of antiretroviral treatment since 1998; and to examine relationships between the practice of unprotected anal intercourse and the perception of antiretroviral treatment.

Methods

Four cross-sectional surveys (1,2) have been carried out since 1993, with the participation of a community-based gay organisation (Stop sida). A convenient sample of MSMs was recruited each year in three saunas, two sex shops, a pick up site in a public park and through a mailing list of a community-based gay organisation. All venues were located in Barcelona.

The questionnaire, used since 1995, was validated and adapted from one developed by the Institut Universitaire de Médecine Sociale et Préventive, Lausanne (13). It collects information about demographic data, social network, sexual practices with steady and casual partners, drug use, HIV testing behaviour, and, since 1998, knowledge and perception of antiretroviral treatment and post-exposure prophylaxis. The behaviour described refers to the 12 months before the survey.

Around 2000 anonymous self-administered questionnaires were distributed each year by four health educators of a gay association. Questionnaires were returned by mail. In addition, to estimate the prevalence of HIV infection, around 300 saliva samples were requested each year to determine HIV antibodies using standard enzymatic immunoassay techniques (14). Furthermore, between 1000 and 1400 questionnaires were also sent to all male members of a gay association in Catalonia.

A descriptive statistical analysis was performed using χ 2 for comparisons of proportions and logistic regression to adjust estimates. The SPSS-PC V10 statistical software package was used. When differences were not statistically significant between the three surveys, only the results from the 2000 survey are presented. Unprotected anal intercourse (UAI) with a steady partner and with casual partners was calculated as the proportion of those who never or occasionally used a condom during the previous 12 months when practising anal intercourse with steady or casual partners. Statements about knowledge and perception of antiretroviral treatment (ARV) had five response options: strongly agree (1), agree (2), disagree (3), strongly disagree (4), do not know (5). For analysis, options have been collapsed (1+2 = agree; 3+4 = disagree) and option 5 (do not know) has been removed.

Table 1

Age group, HIV testing and sexual behaviours of men who have sex with men

 

1995

(n = 741)

% (n/N)

1998

(n = 713)

% (n/N)

2000

(n= 828)

% (n/N)

p2


Age group (years)

 
≤ 19

0.6 (4/718)

0.6 (4/623)

0.6 (5/803)

 
20-29
35.5 (255/718)
28.7 (179/623)
22.2 (178/803)
< 0.001

30-39
42.1 (302/718)
45.1 (281/623)

47.6 (382/803)

> 40

21.9 (157/718)

25.5 (159/623)

29.6 (238/803)


Already tested for HIV
67.1 (497/741)
75.5 (529/701)
78 (637/817)
< 0.001

AOR1

1

1.5 [1.2-2.0]

1.7 [1.4-2.2]


Self-reported prevalence of HIV
16.4 (78/475)
16.6 (87/524)
18.8 (117/622)
 

AOR1

1

0.9 [0.6-1.3]

1.1 [0.8-1.5]

ns


Saliva prevalence of HIV
14.2 (43/303)
15.5 (43/277)
17.9 (55/308)
ns

AOR1

1

1.1 [0.7-1.9]

1.3 [0.8-2.1]

 

Number of male sexual partners

 

 
0

2.2 (15/683)

2.7 (19/694)

0.8 (6/791)

 
1

14.5 (99/683)

12.4 (86/694)

10.9 (86/791)

 
2-10

38.1 (260/683)

30.7 (213/694)

30.5 (241/791)

 
> 10 (11-450)
45.2 (309/683)
54.2 (376/694)

57.9 (458/791)

 

AOR1 (<=10 vs >10)

1

1.3 [1.1-1.7]

1.7 [1.3-2.0]

< 0.001


Unprotected anal intercourse with steady partner

53.2 (189/353)

52.2 (193/370)

58.9 (249/423)
 

AOR1

1

0.9 [0.7-1.3]

1.3 [0.9-1.7]

ns


Unprotected anal intercourse with casual partners

24.2 (25/393)

21.8 (103/472)

25.4 (149/586)

 

AOR1

1

0.8 [0.6-1.1]

[0.8-1.4]

ns


Ejaculation in steady partner's mouth

20.1 (88/437)

25.2 (106/420)

29.3 (141/482)

 

AOR1

1

1.3 [0.9-1.8]

1.7 [0.3-2.3]

= 0.006


Ejaculation in casual partners mouth

7.2 (40/558)

7.1 (40/567)

12 (84/699)

 

AOR1

1

1.1 [0.7-1.8]

1.9 [1.2-2.8]

= 0.002


Drug use before or during sex
 
Alcohol

47.5 (335/706)

59.9 (398/669)
55.2 (430/779)
< 0.001
AOR1

1

1.6 [1.3-2.1]
1.5 [1.2-1.9]
 
Cannabis

19.7 (141/717)

 

24.5 (160/653)
26.6 (204/766)
= 0.006
AOR1
1
1.3 [0.9/1.7]
1.5[1.2/1.9]
 
Cocaine
9.6 (69/718)
16.7 (108/645)
22.5 (171/761)
< 0.001
AOR1
1
1.9 [1.3/2.6]
3.0 [2.2-4.1]
 
Ecstasy
8.2 (59/716)
10.6 (68/642)
13.3 (100/754)
= 0.008
AOR1
1
1.4 [0.9/2.1]
2.0 [1.4/2.9]
 
Amphetamines
1.3 (9/715)
3.3 (21/642)
3.9 (29/741)
= 0.006
AOR1
1
3.0 [1.3/6.6]
3.7 [1.7/7.9]
 
Poppers
28.4 (204/718)
33.9 (223/657)
38.3 (298/778)
< 0.001

AOR1

1

1.2 [0.9/1.6]

1.6 [1.3-1.9]

 

ns: non significant

1 AOR: Adjusted Odds Ratio for age and 95% Confidence Interval

2 Mantel-Haenzel χ 2

 

Table 2

Knowledge and perception (agrees versus disagrees) regarding combined antiretroviral therapies (ARV). Comparison between 1998 and 2000. Logistic regression

 

1998

(n = 713)

% (n/N)

2000

(n= 828)

% (n/N)

p1

AOR2

[CI]

ARV therapies can cure HIV infection

11.7 (58/495)

5.6 (31/556)

<0.001

0.4[0.3-0.7]

Side-effects of ARV therapies are very uncomfortable

70.2 (288/410)

83.5 (416/498)

<0.001

2.4[1.7-3.3]

HIV positive persons taking ARV are unlikely to transmit HIV

8.3 (40/482)

7.5 (40/535)

ns

0.9[0.6-1.5]

With ARV it is likely to avoid HIV infection after a potential sexual risk exposure

7.4 (36/484)

21.5 (106/493)

<0.001

3.8[2.4-5.9]

Because of ARV MSM are less afraid of becoming HIV positive

34.4 (176/512)

46.1 (277/601)

<0.001

1.6[1.2-2.1]

Because of ARV I am less afraid of becoming HIV positive

22.4 (122/545)

30.2 (178/590)

=0.003

1.5[1.1-2.0]

Because of ARV MSM pay less attention to prevention

25.4 (133/523)

41.2 (249/604)

<0.001

2.2[1.7-2.9]

Because of ARV I pay less attention to prevention

6 (34/567)

11.4 (69/605)

<0.001

2.2[1.4-3.5]

Because of ARV MSM are less worried if they take sexual risks

21.6 (110/510)

30.8 (184/597)

<0.001

1.7[1.2-2.2]

Because of ARV I am less worried if I take sexual risks

7.2 (40/558)

11.6 (69/596)

<0.001

1.6[1.1-2.5]

ns: non significant

1 Mantel-Haenzel χ 2

2 AOR: Odds ratio ajusté par l’âge et intervalle de confiance à 95% / Adjusted Odds Ratio for age and 95% Confidence Interval.
Reference: 1998

 

Table 3

Association of unprotected anal intercourse (UAI) with casual partners versus with casual partners with statements about antiretroviral therapies ARV). Logistic regression

 

UAI*

no UAI*

p1

AOR2 [CI]

HIV positive persons taking ARV are unlikely to transmit HIV

13.9 (21/151)

8 (45/564)

= 0.02

1.9[1.1-3.4]

With ARV It is likely to avoid HIV infection after a potential sexual risk exposure

23.1 (33/143)

14.7 (79/538)

= 0.01

1.7[1.0-2.8]

Because of ARV I am less afraid of becoming HIV positive

40.7 (68/167)

25.7 (162/631)

< 0.001

1.9[1.3-2.8]

Because of ARV I pay less attention to prevention

29.1 (52/179)

6 (39/650)

< 0.001

6.2[3.8-10.1]

Because of ARV I am less worried if I take sexual risks

29.6 (50/169)

6.5 (42/644)

< 0.001

5.5[3.5-8.9]

ns: non significant

1 Mantel-Haenzel χ 2

2 AOR: Adjusted Odds Ratio for age and 95% Confidence Interval.

* UAI: Unprotected anal intercourse

 

Results

The questionnaire return rate ranged from 29% (741/2543) in 1995 to 27% (713/2775) in 1998, and 24% (828/3445) in 2000. The mean age increased over the years (33.7, 34.8, and 36.1 years old in 1995, 1998, and 2000, respectively, p<0.001). With the exception of age, the selected samples were similar for demographic characteristics. Most of them had a high level of education (49% were university graduates) and were living in Barcelona (70%).

The vast majority of the homosexual men studied had been tested for HIV antibodies previously, and this proportion increased over the years surveyed (table 1). We also observed an increase in the proportion of those who had been tested more than once (40.9%, 50.9%, and 53.4% in 1995, 1998, and 2000, respectively). Self-reported prevalence of HIV was 16.4% [95% confidence interval: 13.1-19.8] in 1995; 16.6% [13.4-20.5] in 1998; and 18.8% [15.7-21.9] in 2000. Prevalence of HIV estimated in the saliva samples was 14.2% [95% confidence interval: 10.3-18.1] in 1995, 15.5% [11.3-19.8] in 1998, and 17.9% [13.6-22.2] in 2000. Although both self-reported and saliva prevalence of HIV show an increasing trend, neither are statistically significant.

Most respondents had sexual relationships with both steady and casual partners (53%), more than a third with casual partners only (36%), and 11% with steady partners only. Nearly a third had sexual encounters several times per week, and 14% irregularly, but with intensive periods. Although the frequency of sexual activity seems to be stable, the number of sexual partners shows an increasing trend. In 2000, 58% had more than 10 sexual partners during the previous year (45% and 54%, respectively, in 1995 and 1998, p<0.001). The association remains significant after adjusting for age (table 1).

Anal intercourse was practised by 87% with a steady partner and 83% with casual partners, and oro-genital sex by 98% and 96%, respectively. Unprotected anal intercourse with a steady partner was reported by 59%, and with casual partners by 25% (table 1). In both cases the proportion of UAI showed a slight increasing trend, but was not statistically significant. Similarly, we observed an increasing proportion of ejaculation in the partner’s mouth that only remained significant for casual partners after adjusting for age (table 1).

During the previous 12 months, 31% of the participants had experienced at least one condom breakage and 22% condom slippage. The participants who always used lubricants during anal intercourse had fewer accidents with condoms than those who did not. However, less than half of the men who used condoms during anal intercourse always used lubricants (40%) and of these, 18% chose liposoluble lubricants (oil, petroleum jelly, cream, etc) that can reduce the elasticity of the condom and thus increase the risk of breakage.

Prevalence of drug use before or during sexual encounters in the 12 months before the survey was high and, with the exception of alcohol, the use of drugs shows a clearly increasing trend over the years and remained significant after adjusting for age (table 1).

Responses to statements about ARV are presented in table 2. Although participants in 2000 seemed to be better informed, 5.6% still thought that "ARV therapies can cure HIV infection". More respondents than in the previous survey reported "side effects of ARV therapies are very uncomfortable" (70.2% and 83.5% in 1998 and 2000, respectively). In 2000, more MSMs had heard about post-exposure prophylaxis (PEP) than in 1998: 21.5% believed that "with ARV it is possible to avoid HIV infection after a potential sexual risk exposure" versus 7.4% in 1998. In general in 2000, there was a more optimistic perception regarding ARV therapy : a higher proportion than in 1998 believed that "with ARV, MSMs are less afraid of becoming HIV positive", and "pay less attention to prevention", and are "less worried if they take sexual risks".

We found a significant association between the statements that suggest optimistic perception of ARV therapy and unsafe sex, and this remained significant after adjusting for age, year of survey, and known serological status (table 3). Participants who agree that "HIV positive persons taking ARV therapy are unlikely to transmit HIV" are 1.9 times more likely to have UAI with casual partners, and those who agree that "with ARV it is likely to avoid HIV infection after a potential sexual risk exposure" are 1.7 times more likely. Similarly, those who report "being less afraid of becoming HIV positive", "paying less attention to prevention" or "being less worried if they take sexual risks" are also more likely to have UAI (odds ratio 1.9, 6.2, and 5.5, respectively).

Comment

In general, the results of this fourth survey did not show significant changes in the prevalence of HIV and in sexual risk behaviour of MSMs surveyed in Barcelona. Only three indicators showed a statistically significant increase: a higher proportion of participants than previous surveys reported having had more than 10 male sexual partners in the 12 months before the survey; a higher proportion of ejaculation in the mouth with casual partners; and a higher prevalence of drug use during or before sexual encounters. This is not consistent with the recently reported increase in both the HIV incidence rate (3-5) and in HIV risk behaviour (9,10) among MSMs from other countries.

Although cross-sectional studies suffer from methodological limitations, their repeated use over time with a standardised approach provides a useful way to describe the evolution of the HIV epidemic among MSMs. The return rate of questionnaires was not high, but was similar in the three surveys, and higher than in ‰ other studies (13). We cannot, however, generalise findings from this study to all MSMs in Barcelona. Self-reported sexual behaviour may also be subject to measurement error, but we attempt to reduce this by using an anonymous self-completed questionnaire.

The results of this fourth survey, however, still show a high prevalence of HIV among MSMs in Barcelona, a high level of unprotected sex with both steady and casual partners, and a high prevalence of drug use during or before sexual intercourse. In addition, among those who used condoms, accidents in the handling of condoms continued to be considerable and despite educational campaigns, the use of liposoluble lubricants is high. We also observed an increased trend of optimism regarding the efficacy of HIV combination treatment, a decreased worry about HIV infection because of PEP, and a significant association between optimism and UAI with casual partners, as reported in other studies (11,12).

We conclude that there is no clear evidence of an increase in sexual risk behaviour among MSMs, but the optimism regarding ARV may lead to a greater relaxation in protective measures in the near future. In addition, the high prevalence of HIV and risk behaviour, the difficulties to maintain safer sex practices ("AIDS burnout"), the longer survival of people infected with HIV, and the ineffectiveness of treatments due to drug resistant HIV strains may make the control of the epidemic difficult. Further and more creative interventions that take into account the new scenario are needed.

Acknowledgements

The authors thank Stop sida, the association that carried out the survey fieldwork, Kati Zaragoza, Rafa Muñoz, and all the men who voluntarily gave their time to answer the questionnaire.


 

References

References :

1. Centre d’Estudis Epidemiològics sobre la Sida de Catalunya (CEESCAT) (Spain). Sistema integrat de vigilància epidemiològica de l’HIV/sida a Catalunya (SIVES): informe anual 2000. [13]. 2001. Barcelona, Generalitat de Catalunya, Departament de Sanitat i Seguretat Social. Document Tècnic CEESCAT.

2. Centre d’Estudis Epidemiològics sobre la Sida de Catalunya (CEESCAT) (Spain). Monitoratge de la prevalença i del nivell de la prevenció de la infecció per l’HIV en la comunitat d’homes homosexuals i en usuaris de drogues per via parenteral. [11]. 2000. Barcelona, Generalitat de Catalunya, Departament de Sanitat i Seguretat Social. Document Tècnic CEESCAT.

3. Kellogg T, McFarland W, Katz M. Recent increases in HIV seroconversion among repeat anonymous testers in San Francisco. AIDS 1999; 13: 2303-4.

4. Hogg RS, Weber AE, Chan K, Martindale S, Darrel C, Miller ML, et al. Increasing incidence of HIV infections among young gay and bisexual men in Vancouver. AIDS 2001; 15: 1321-2.

5. del Romero J, Castilla J, García S, Clavo P, Ballesteros J, Rodriguez C. Time trend in incidence of HIV seroconversion among homosexual men repeatedly tested in Madrid, 1988-2000. AIDS 2001; 15: 1319-21.

6. CDC. Increases in unsafe sex and rectal gonorrhea among men who have sex with men. San Francisco, California, 1994-1997. MMWR Morb Mortal Wkly Rep 1999; 48: 45-8.

7. Stole IG, Dukers NH, de Wit JB, Fennema JS, Coutinho RA. Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect 2001; 77: 184-6.

8. Fox KK, del Rio C, Holmes KK, Hook EW, Judson FN, Knapp JS, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health 2001; 91: 959-64.

9. Ekstrand ML, Stall RD, Paul JP, Osmond DH, Coates TJ. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS 1999; 13: 1525-33.

10. Dodds JP, Nardone A, Mercey DE, Johnson AM. Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. Br Med J 2000; 320: 1510-1.

11. Van de Ven P, Kippax S, Knox S, Prestage G, Crawford J. HIV treatment optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS 1999; 13: 2289-94.

12. Van de Ven P, Prestage G, Crawford J, Grulich A, Kippax S. Sexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000. AIDS 2000; 14: 2951-3.

13. Moreau-Gruet F, Dubois-Arber F. Evaluation de la stratégie de prévention du Sida en Suisse: Phase 6: 1993-1995. Les hommes aimant d’autres hommes. Etude 1994. Lausanne: Institut Universitaire de Médecine Sociale et Préventive, 1995.

14. Vall Mayans M, Casabona J, Rabella N, De Miniac D, Ad Hoc Group for the Comparative Saliva and Serum Study. Testing of saliva and serum for HIV in high-risk populations. Eur J Clin Microbiol Infect Dis 1995; 14: 710-3.

 



Back to Table of Contents
en es fr it
Previous

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved